Dr. Frank Ferrone's lab at Drexel University focuses on understanding sickle cell disease and improving treatments for it. The research aims to uncover how fetal hemoglobin can reduce the harmful effects of sickle hemoglobin, helping to optimize existing gene therapies and discover new drug treatments. By investigating the basic mechanisms of hemoglobin behavior, the lab contributes to better therapeutic strategies for this widespread condition.